(Q42756618)

English

Selegiline, or the problem of early termination of clinical trials. The clinical questions are not well answered, and probably never will be.

scientific article published on April 1998

Selegiline, or the problem of early termination of clinical trials

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

6 November 2017

0 references

Selegiline, or the problem of early termination of clinical trials. The clinical questions are not well answered, and probably never will be. (English)

1 reference

Europe PubMed Central

6 November 2017

author name string

Breteler MM

1

1 reference

Europe PubMed Central

6 November 2017

language of work or name

0 references

publication date

1 April 1998

1 reference

Europe PubMed Central

6 November 2017

1 reference

Europe PubMed Central

6 November 2017

316

1 reference

Europe PubMed Central

6 November 2017

7139

1 reference

Europe PubMed Central

6 November 2017

1182-1183

1 reference

Europe PubMed Central

6 November 2017

Investigation by Parkinson's Disease Research Group of United Kingdom into excess mortality seen with combined levodopa and selegiline treatment in patients with early, mild Parkinson's disease: further results of randomised trial and confidential i

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1112980

27 May 2018

Unexpected findings of study of selegiline have not been treated with caution its authors advised.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1112980

27 May 2018

Selegiline and mortality in Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1112980

27 May 2018

Comparison of therapeutic effects and mortality data of levodopa and levodopa combined with selegiline in patients with early, mild Parkinson's disease. Parkinson's Disease Research Group of the United Kingdom

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1112980

27 May 2018

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/9552992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of Parkinson's disease in the elderly: The Rotterdam Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9552992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJ.316.7139.1182

1 reference

Europe PubMed Central

6 November 2017

release_4im5b6euczatlnjlii5rcnrtki

1 reference

https://api.fatcat.wiki/v0/release/4im5b6euczatlnjlii5rcnrtki

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

6 November 2017

1 reference

Europe PubMed Central

6 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42756618&oldid=1837919008"